GPLD1 and ovarian cancer: On the contrary, Dionísio de Sousa et al. observed that higher expression of low‐density lipoprotein receptor‐related protein 1B, which is one of the endocytic low‐density lipoprotein receptor superfamily, in PLD‐treated ovarian cancer patients was associated with prolonged PFS.29